General MedicationsORALGeneric
URACIL MUSTARD
URACIL MUSTARD
Standard Dose
1MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview URACIL MUSTARD is listed in Drugs@FDA under application 012892 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient URACIL MUSTARD Form and strength CAPSULE;ORAL - 1MG Sponsor SHIRE Submission history Latest submission status date: 1999-05-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview URACIL MUSTARD is listed in Drugs@FDA under application 012892 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient URACIL MUSTARD Form and strength CAPSULE;ORAL - 1MG Sponsor SHIRE Submission history Latest submission status date: 1999-05-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.